NIH-funded research Career grant

Understanding how the immune system affects mitochondrial diseases.

Official title: Mechanisms of Innate Immune Activation in Mitochondrial Disease Onset and Progression

Funded at Seattle Children's Hospital · NIH-11033840 · Data updated 2026-11-12

This study is looking at how the body's natural immune system affects the development and worsening of Leigh syndrome, a serious brain condition caused by genetic mitochondrial diseases, to find new ways to help treat it.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2028
Funding year2025
Award (this year)$122,562
NIH project number1K01AI187782-01
Project IDNIH-11033840 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Leigh syndrome or other genetic mitochondrial diseases.

Less likely to help

Patients with mitochondrial diseases that do not involve immune system activation may not benefit from this research.

What this research studies

This research investigates the role of the innate immune system in the onset and progression of genetic mitochondrial diseases, particularly focusing on Leigh syndrome, a severe neurological condition. By studying how immune activation contributes to disease mechanisms, the research aims to uncover potential pathways for therapeutic intervention. The approach involves examining immune responses in animal models to better understand the relationship between mitochondrial dysfunction and immune activation. This could lead to new strategies for treating these complex diseases.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective therapies for patients suffering from genetic mitochondrial diseases.

How similar studies have gone: Previous research has shown promising results in understanding immune mechanisms in other diseases, suggesting potential for success in this area as well.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Hanaford, Allison Rose — Seattle Children's Hospital
  • Study coordinator: Hanaford, Allison Rose

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.